Steris PLC (STE)
Stock Price Chart
Key Info
| Market Cap | 15.82B |
| Revenue (ttm) | 3.00B |
| Net Income (ttm) | 411.21M |
| Shares Out | 85.05M |
| EPS (ttm) | 4.80 |
| PE Ratio | 38.74 |
| Forward PE | 29.59 |
| Dividend | $1.60 |
| Dividend Yield | 0.86% |
Stock Quote
| Trading Day | Oct 21, 2020 |
| Last Price | $185.95 |
| Previous Close | $186.34 |
| Change ($) | -0.39 |
| Change (%) | -0.21% |
| Day's Open | 186.23 |
| Day's Range | 185.66 - 187.56 |
| Day's Volume | 181,168 |
| 52-Week Range | 105.69 - 192.97 |
More Stats
| Market Cap | 15.82B |
| Enterprise Value | 16.76B |
| Earnings Date (est) | Nov 2, 2020 |
| Ex-Dividend Date | Aug 26, 2020 |
| Shares Outstanding | 85.05M |
| Float | 84.59M |
| EPS (basic) | 4.86 |
| EPS (diluted) | 4.80 |
| FCF / Share | 4.57 |
| Dividend | $1.60 |
| Dividend Yield | 0.86% |
| Earnings Yield | 2.58% |
| FCF Yield | 2.45% |
| Payout Ratio | 30.50% |
| Shares Short | 1.28M |
| Short Ratio | 2.47 |
| Short % of Float | 1.51% |
| Beta | 0.66 |
| PE Ratio | 38.74 |
| Forward PE | 29.59 |
| P/FCF Ratio | 40.76 |
| PS Ratio | 5.27 |
| PB Ratio | 4.56 |
| Revenue | 3.00B |
| Operating Income | 540.89M |
| Net Income | 411.21M |
| Free Cash Flow | 388.04M |
| Net Cash | -947.26M |
| Net Cash / Share | -11.14 |
| Gross Margin | 44.04% |
| Operating Margin | 18.01% |
| Profit Margin | 13.70% |
| FCF Margin | 12.92% |
| ROA | 6.50% |
| ROE | 12.21% |
| ROIC | 18.50% |
Analyst Summary
Analyst Consensus: Overweight
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|
| Revenue | 3,031 | 2,782 | 2,620 | 2,613 | 2,239 | 1,850 | 1,622 |
| Revenue Growth | 8.94% | 6.19% | 0.28% | 16.71% | 21% | 14.06% | - |
| Gross Profit | 1,320 | 1,175 | 1,093 | 1,026 | 895 | 774 | 650 |
| Operating Income | 537 | 411 | 400 | 226 | 213 | 227 | 207 |
| Net Income | 408 | 304 | 291 | 110 | 111 | 135 | 129 |
| Shares Outstanding | 84.81 | 84.59 | 84.85 | 84.93 | 85.90 | - | - |
| Earnings Per Share | 4.76 | 3.56 | 3.39 | 1.28 | 1.56 | 2.25 | 2.17 |
| EPS Growth | 33.71% | 5.01% | 164.84% | -17.95% | -30.67% | 3.69% | - |
| Dividend Per Share | 1.45 | 1.33 | 1.21 | 1.09 | 0.25 | - | - |
| Dividend Growth | 9.02% | 9.92% | 11.01% | 336% | - | - | - |
| Operating Cash Flow | 591 | 540 | 458 | 424 | 255 | 246 | 210 |
| Capital Expenditures | -210 | -184 | -163 | -168 | -126 | -84.43 | -81.59 |
| Free Cash Flow | 380 | 355 | 294 | 256 | 129 | 162 | 128 |
| Cash & Equivalents | 320 | 221 | 202 | 283 | 249 | 168 | - |
| Total Debt | 1,284 | 1,183 | 1,316 | 1,478 | 1,568 | 621 | - |
| Net Cash / Debt | -965 | -963 | -1,114 | -1,195 | -1,319 | -453 | - |
| Assets | 5,426 | 5,073 | 5,200 | 4,924 | 5,346 | 2,097 | - |
| Liabilities | 2,019 | 1,887 | 1,983 | 2,114 | 2,308 | 1,024 | - |
| Book Value | 3,394 | 3,178 | 3,206 | 2,799 | 3,023 | 1,072 | - |
Company Profile
Company Details
| Full Name | Steris PLC |
| Country | Ireland |
| Employees | 13,000 |
| CEO | Walter M. Rosebrough |
Stock Information
| Ticker Symbol | STE |
| Stock Exchange | New York Stock Exchange |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Unique Identifier | NYSE: STE |
| IPO Date | June 1, 1992 |
Description
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services. This segment offers its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, such as instrument and endoscope repair and maintenance solutions; custom process improvement consulting services; and outsourced instrument sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The company was founded in 1985 and is based in Dublin, Ireland.